OK DONT SHOOT THE MESSENGER
Yes I'm a Trader ,,, so I can only formulate strategy on the facts, yes I make my money on the way to the finish line not when the Company crosses the finish line... Yes Coads I have trading parcels that will be sold on the way back up that I bought @ 10c , 11c , 11.5c
Company had $8,610,000 on 31st March
Estimated Quarters 1.55 quarters
Unless there is a Grant there will be the requirement to satisfy the ASX Regs "{no matter what" or NUZ will be suspended at the next 4C.
Now if the FDA Hold is lifted the SP should climb swiftly back to 20c reducing the dilution but also providing a Greenlight for a Partner...
So when the Hold is lifted NUZ will need to have funds ready for Healey to commence... more than likely paid by the new Partner...NZT
5.1(c) Total funds held in bank as at 31 March 2025 8,610
8.5.1(d) Estimated quarters of total funding available (item 8.5.1(c)
divided by item 8.1) 1.55
Appendix 4C
Quarterly cash flow report for entities subject to Listing Rule 4.7B
ASX Listing Rules Appendix 4C (17/07/20) Page 6
+ See chapter 19 of the ASX Listing Rules for defined terms.
8.6 If item 8.5 is less than 2 quarters, please provide answers to the following questions: N/A
8.6.1 Does the entity expect that it will continue to have the current level of net operating
cash flows for the time being and, if not, why not?
Cash outflows for the March quarter were higher than usual, primarily driven by one-off
costs related to preparation for the upcoming Healey ALS Trial. Expenditure is expected to
normalise over the coming months, with a return to more typical spending levels anticipated
until the commencement of the future clinical trial program.
8.6.2 Has the entity taken any steps, or does it propose to take any steps, to raise further
cash to fund its operations and, if so, what are those steps and how likely does it
believe that they will be successful?
The Company remains focused on prudent capital management, with ongoing
implementation of cost-saving initiatives and close monitoring of operating expenditures. In
parallel, the Company continues to assess strategic commercial opportunities and capital
management options to support business operations and long-term value creation.
Management is confident in its ability to secure appropriate funding solutions in a timely
manner, as required.
8.6.3 Does the entity expect to be able to continue its operations and to meet its business
objectives and, if so, on what basis?
Yes, the Company expects to be able to continue its operations and meet its business
objectives on an ongoing basis. Achieved by prudently utilising available cash and
executing an appropriate commercial and / or capital solution as and when required.
Expand
(20min delay)